Farther Finance Advisors’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$71.6K Sell
6,360
-405
-6% -$5.39K ﹤0.01% 3129
2026
Q2
$98.8K Buy
6,765
+6,669
+6,947% +$88.1K ﹤0.01% 2713
2026
Q1
$1.33K Buy
+96
New +$1.45K ﹤0.01% 5030

Other funds holding CLBT

Farther Finance Advisors's CLBT Position: Q3 2026 in Review

Farther Finance Advisors reduced its Cellebrite (CLBT) stake by 6% in Q3 2026, selling an estimated $5.39K and leaving 6,360 shares worth $71.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3129.

Farther Finance Advisors first reported a position in CLBT in Q1 2026 and has held it in 3 quarters since. The position peaked at $98.8K in Q2 2026. 5 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • Farther Finance Advisors held 6,360 shares of Cellebrite worth $71.6K as of Q3 2026.
  • Farther Finance Advisors sold 405 Cellebrite shares in Q3 2026, an estimated $5.39K.
  • Cellebrite made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3129 holding.
  • Farther Finance Advisors first reported a position in Cellebrite in Q1 2026 and has held it in 3 quarters since.
  • Farther Finance Advisors's Cellebrite position peaked at $98.8K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.